Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled Trial

INTRODUCTION: The prevalence of type 2 diabetes (T2D) has risen substantially in China, where its pathophysiology is primarily characterized by insulin resistance (IR). Alleviating IR may help with the management of T2D in the Chinese population. Pioglitazone and sitagliptin are two hypoglycemic med...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fang, Tang, Lizhi, Li, Jing, Yan, Zhe, Li, Juan, Tong, Nanwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987276/
https://www.ncbi.nlm.nih.gov/pubmed/33776461
http://dx.doi.org/10.2147/DMSO.S293307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987276/
https://www.ncbi.nlm.nih.gov/pubmed/33776461
http://dx.doi.org/10.2147/DMSO.S293307

Ejemplares similares